Company Filing History:
Years Active: 2025
Title: Thomas H. King: Innovator in COVID-19 Treatment
Introduction
Thomas H. King is a notable inventor based in Culver City, California. He has made significant contributions to the field of medical research, particularly in the treatment of COVID-19. His innovative approach focuses on utilizing replication-defective adenoviruses to combat the virus effectively.
Latest Patents
Thomas H. King holds a patent for "Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein." This patent presents compositions and methods aimed at the prevention and treatment of coronavirus disease. The composition includes a recombinant entity that encodes a nucleocapsid protein of coronavirus 2 (CoV2) and/or a spike protein of CoV2.
Career Highlights
King is currently associated with Nantcell, Inc., where he continues to work on groundbreaking research in the field of virology. His dedication to developing effective treatments for viral infections has positioned him as a key figure in the medical research community.
Collaborations
One of his notable collaborators is Kayvan R. Niazi, with whom he has worked closely on various projects related to COVID-19 treatment.
Conclusion
Thomas H. King is a pioneering inventor whose work in developing treatments for COVID-19 showcases his commitment to advancing medical science. His innovative patent reflects the potential for new therapeutic strategies in combating viral diseases.